Primary sclerosing cholangitis (PSC) is an incurable, fibroinflammatory biliary disease for which there is no effective pharmacotherapy. We recently reported cholangiocyte senescence as an important phenotype in PSC while others showed that portal macrophages accumulate in PSC. Unfortunately, our ability to explore cholangiocyte senescence and macrophage accumulation has been hampered by limited in vitro models. Thus, our aim was to develop and characterize a three-dimensional (3D) model of normal and diseased bile ducts (cholangioids) starting with normal human cholangiocytes (NHC), senescent NHC (NHC-sen), and cholangiocytes from PSC patients. In 3D culture, NHCs formed spheroids of~5000 cells with a central lumen of~150 μm. By confocal microscopy and western blot, cholangioids retained expression of cholangiocyte proteins (cytokeratin 7/19) and markers of epithelial polarity (secretin receptor and GM130). Cholangioids are functionally active, and upon secretin stimulation, luminal size increased by~80%. Cholangioids exposed to hydrogen peroxide exhibited cellular senescence and the senescence-associated secretory phenotype (SASP; increased IL-6, p21, SA-β-Gal, yH2A.x and p16 expression). Furthermore, cholangioids derived from NHC-sen or PSC patients were smaller and had slower growth than the controls. When co-cultured with THP-1 macrophages, the number of macrophages associated with NHC-sen or PSC cholangioids was five-to seven-fold greater compared to co-culture with non-senescent NHC. We observed that NHC-sen and PSC cholangioids release greater number of extracellular vesicles (EVs) compared to controls. Moreover, conditioned media from NHC-sen cholangioids resulted in an~2-fold increase in macrophage migration. In summary, we developed a method to generate normal and diseased cholangioids, characterized them morphologically and functionally, showed that they can be induced to senescence and SASP, and demonstrated both EV release and macrophage attraction. This novel model mimics several features of PSC, and thus will be useful for studying the pathogenesis of PSC and potentially identifying new therapeutic targets.
obliteration. Recently, advances in the field of in vitro research have been made with the introduction of three-dimensional (3D) cell culturing techniques, as 3D cultures can be made to resemble the morphology of organs and recapitulate better in vivo biologic processes. 5 Three-dimensional in vitro cellular clusters that exhibit spontaneous formation, growth, and polarity, termed organoids, have been generated from embryonic stem cells, pluripotent stem cells, as well as from a number of primary cell types. [6] [7] [8] [9] To date, several manuscripts have described the development of 3D cultures from cholangiocytes, the majority of them reporting the formation of 3D cultures of cholangiocytes that were differentiated from pluripotent or embryonic stem cells [10] [11] [12] [13] using this approach to model biliary diseases such as Alagille syndrome, polycystic liver disease, and cystic fibrosis. 10, 11 More recently, Spirli and colleagues generated organoids from cholangiocytes from mice with polycystic liver disease and studied the effects of adenylyl cyclase inhibition on organoid size. 14 Also, Waisbourd-Zinman et al 15 demonstrated a link between a plant-derived toxin and development of biliary atresia-associated cellular changes using 3D cultures of mature and freshly isolated extrahepatic neonatal mouse cholangiocytes. Previously, using collagen matrices, our group reported the formation of 3D hepatic cysts from bile ducts from normal rats and rats with polycystic kidney disease. 16 Thus, to extend and refine these efforts, our objectives here were to: (i) develop a simple, reproducible 3D in vitro model of normal human and diseased cholangiocytes, which we have termed cholangioids, beginning with cholangiocyte cell lines; (ii) characterize the morphology, size, cell number, and polarity of the cholangioids; (iii) assess the functionality of the cholangioids; and (iv) begin to utilize our model to mimic selected features of PSC, such as cellular senescence and macrophage recruitment. Herein, we describe a novel, in vitro 3D model of PSC, which will be useful to understand the mechanisms of PSC pathogenesis, the interactions between PSC bile ducts and immune cells, and potentially to develop new therapeutic targets.
MATERIALS AND METHODS
The normal human cholangiocyte cell line (NHC) was isolated from a normal human liver and characterized by Joplin et al 17 and was a gift from Dr Juan Medina (University of Navarra, Pamplona, Spain). NHCs passages 10-15 were used in this study. We also used a cell line derived from a patient with PSC previously described by us. 18 The human macrophage THP-1 cell line was purchased from the American Type Culture Collection (Manassas, VA) and cultured according to their protocol.
Cholangioid Media
Media previously reported for culturing cholangiocytes in monolayers (H69 media) 19 was supplemented with 5 ng/ml of recombinant epidermal growth factor (EGF) (Sigma-Aldrich) and 5% of growth factor reduced, phenol free Matrigel (Corning, New York, NY).
3D Cultures
To prevent the growth of cells in monolayer, tissue culture dishes or glass slide chamber slides were pre-coated with a polyHEMA (Sigma-Aldrich, St Louis, MO) solution (125 μl/ cm 2 ). 20 A cell suspension containing B6000 NHCs or PSC cells and 56 μl of growth factor reduced, phenol-free Matrigel/ cm 2 was plated on the polyHEMA-coated surfaces and incubated at 37°C, 5% CO 2 for 2 h as reported elsewhere. 21 Then, 250 μl of cholangioid media were added per well. Cholangioid media was changed every 4 days and the cells kept in culture for 5-20 days.
Isolation and Counting Cells of Cholangioids
Five-and twenty-day single cholangioids of up to 150 μm were isolated by manually pipetting using 10 μl pipettes under a Zeiss Axiovert 25 microscope. The cholangioids were placed in 25 μl of Dispase (Corning) and incubated at 37°C, 5%CO 2 for 2 h to dissociate the cells. Single cells were counted using a hemocytometer and Trypan blue. The cholangioid size was calculated by averaging the vertical, horizontal, and diagonal diameters of each cholangioid using the ImageJ software.
Phase Contrast and Confocal Live Microscopy
Pictures of five-and twenty-day cholangioids were taken via phase contrast, differential interference contrast (DIC), and confocal microscopy using a Nikon Eclipse TE 300 and a Zeiss LSM 780 microscopes.
Immunofluorescent Microscopy
Cholangioids were fixed with 4% paraformaldehyde, permeabilized for 45 min at 4°C, 21 blocked with 1% donkey serum, and incubated overnight at 4°C with antibodies to the following proteins: GM130 (Novus Biologicals, Littleton, CO); SR, CK7, and CK19 (Santa Cruz Biotechnology); acetylated tubulin (Sigma-Aldrich); and IL-6, γH2A.x, CFTR, AE2, and CD11B (Abcam, Cambridge, MA). All antibodies were used at a concentration of 1:100. Following three washes, the cholangioids were incubated with the following secondary antibodies diluted at 1:400: donkey anti-goat IgG-568, donkey anti-rabbit IgG-488, and donkey antimouse-647 (Abcam). Then nuclei were counterstained with DAPI and the chamber slides were stored at 4°C in 20% glycerol/phosphate-buffered saline (PBS).
Transmission Electron Microscopy
Twenty-day cholangioids were fixed in 2.5% glutaraldehyde/ 0.1 M phosphate buffer (PB) at pH 7.4 for 1 h at room temperature. Then, the cholangioids were washed in 0.1 M PB (pH 7.2-7.4) and incubated with 1% OsO 4 in PB for 1 h. After rinsing with PB twice and four times with distilled water, the samples were dehydrated, and then embedded in Spurrs resin and sectioned at 90 nm. Pictures were taken using a Joel 1400 electron microscope (Joel, Peabody, MA, USA).
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Immunogold Transmission Electron Microscopy
Pellets of exosomes (see below for isolation) were fixed in 4% paraformaldehyde/0.1 M PB (1:1 in volume) for 2 h or overnight at 4°C. The samples were then placed on Formvar-carbon-coated nickel grid (200 mesh) and air-dried for 30 min. After saturation of free aldehyde groups by 2% FCS/PBS (fetal calf serum), containing 20 mmol/l glycine for 20 min and blocked with 10% FCS/PBS for 20 min, the grids were incubated with Normal and senescent cholangioids L Loarca et al TSG101 antibody (Santa Cruz, goat M-19) diluted 1:20 with 10% FCS/PBS for 2 h or overnight at 4°C. After washing with 2% FCS/PBS six times (5 min each) and labeling with rabbit anti-goat IgG (Sigma) in 1:500 dilution with 10% FCS/PBS for 1 h, the grids were labeled with protein A-10 nm gold (1:20 diluted with 10% FCS/PBS). The grids were post fixed with 1% gutaraldehyde/PBS for 5 min, washed six times with distilled water drops (3 min each). Then, the grids were contrasted and embedded with a mixture of 4% uranyl acetate and 2% methylcellulose (in 1:9 ratio). The grids were airdried and observed with JEOL 1400 electron microscope.
Western Blotting
Approximately, 5-10 μg of protein were run on 4-20% Mini-PROTEANTGX precast polyacrylamide gels (Bio-Rad Laboratories, Hercules, CA), transferred to nitrocellulose membranes, blocked, and probed with primary antibodies for: CD63, ALIX, TSG101, Actin, CK7, CK19, and GGT1 diluted 1:500 (Santa Cruz Biotechnology). The secondary antibody, donkey-anti-rabbit or mouse-HRP (Jackson Labs, West Grove, PA) was diluted 1:10 000. The signal was developed with the ECL Western Blotting System (GE Healthcare, Little Chalfont, UK) using a Kodak X-Omat (Rochester, NY).
RNA Extraction and Quantitative Real-Time PCR
Twenty-day cholangioids from NHC-control and NHC-sen were collected using Cell Recovery Solution (Corning, Corning, NY) according to the manufacturer's protocol. Total RNA was extracted from cholangioids using the RNeasy Plus Mini Kit (Qiagen). Reverse transcription was performed with 1 μg RNA, using oligo (dT) primer and SuperScript III. Real-time PCR was performed in a volume of 20 μl using Sybr Green Master Mix and QuantStudio3 (Applied Biosystems). Normal and senescent cholangioids L Loarca et al
Exosome Isolation
Twenty-day cholangioids were washed in serum-free H69 media three times. Then, the cholangioids were incubated in serum free H69 media for 24 h at 37°C, 5% CO 2. The conditioned media was collected and processed for differential ultracentrifugation to isolate exosomes as described previously. 22 Secretin Assays 
Freezing Cholangioids and Culture of Frozen Cholangioid Stocks
Media was pipetted out from 20-day cholangioids that were grown in 35 mm dishes. Approximately 1 ml of cold cholangioid media was added to the dish placed on ice. The media was pipetted up and down several times until the Matrigel was dissolved and transferred to a conical tube and spun for 3 min, 4°C, 1500 r.p.m. The media was aspirated and the pellet resuspended in cold cholangioid media containing 10% DMS0 and 10% growth factor reduced, phenol-free Matrigel and stocks prepared in cryovials. The cryovials were placed at − 80°C for 24 h, and then stored in liquid N 2 . To culture frozen cholangioid stocks, the cryovial was placed in a water bath at 37°C for 1 min. The cholangioid suspension was mixed with cold cholangioid media and spun for 3 min at 4°C, 1500 r.p.m. After aspirating the media, the tube was placed in ice and the pellet resuspended in 450 μl of growth factor reduced, phenol-free Matrigel. Then the cholangioid-Matrigel suspension was placed on a polyHEMAcoated 35 mm dish as described earlier.
Co-Cultures
Approximately 10 000 THP-1 cells in suspension were incubated with 20-day-old NHC and PSC cholangioids cultured in glass slide eight-well chamber slides for 24 h at 37°C, 5% CO 2 in cholangioid media. Then the co-cultures were processed for live images or immunofluorescence.
Cell Migration Assay
Human monocytic THP-1 cells (TIB-202, ATCC) were plated at 200 000 cells/well in the upper chamber of a 96-well migration assay (Cell Biolabs, San Diego, CA) and incubated for 6 h with conditioned media (bottom chamber) obtained from NHC-Ctrl or NHC-sen organoids or with media only as a negative control. THP-1 cell migration was then quantitated per manufacturer's instructions.
Statistical Analysis
The data reported represents the mean of 5-12 cholangioids per experiment or fold change ± standard error of the mean. The results were analyzed using Graphpad Prism by two-tailed, paired or unpaired t-test. P-values of o0.05 were considered statistically significant. 
RESULTS
Development and Characterization of Cholangioids
Live images of 5-and 20-day cholangioids using phase contrast and DIC microscopy ( Figure 1a ) showed that, in Matrigel, NHCs form spheroid-like structures that increase in size ( Figure 1b ) and cell number (Figure 1c ). After 20 days in culture, cholangioids start forming tubular structures resembling bile ducts (Figures 2a and b) . Immunofluorescence analysis showed that cholangioids are polarized structures demonstrated by the expression of the Golgi protein, GM130, that has been used as an apical marker in 3D cultures as it shows the localization of the Golgi apparatus toward the lumen of hollow spheroids, 21 as well as the secretin receptor (SR) on the basolateral domain of cholangioids (Figures 3a  and b ). Immunofluorescence and electron microscopy showed that cholangioids also possess primary cilia that extend into a hollow lumen (Figures 3c and 4c ). Moreover, studies performed with 3D structures of other cell types showed that spheroids are hollow structures and that their lumens are formed as the cells in the middle die via apoptosis and autophagy-dependent mechanisms. 21, 23, 24 Electron microscopy analysis shows the luminal space and remnants of dead cells of a cholangioid and the ultrastructure of the NHCs forming cholangioids depicts the cytoskeleton, nucleus, a multivesicular body, and tight junctions between cells as well (Figures 4a, b, and d) . A 3D reconstruction of the z-stacks taken via confocal microscopy confirms that indeed cholangioids have a hollow internal structure ( Supplementary  Figure 1) . Moreover, NHCs forming cholangioids retain expression of the cholangiocyte markers CK7, CK19, and GGT1 (Figures 3d-f ). Immunofluorescence also showed that cholangioids express CFTR, a cell surface chloride transporter, as well as the anion exchanger, AE2 (Supplementary Figure 2 ). We were also able to make stocks of frozen NHC cholangioids, store them for 8 months in liquid N 2, re-culture them, and show that they maintain their morphology and cholangiocyte marker expression ( Supplementary Figure 3) .
Functional Features
As cholangiocytes are known to respond to secretin, we stimulated cholangioids with recombinant human secretin to test whether cholangioids were functionally active. We found that secretin induced a 75.9 ± 6.4% increase (Po0.01) in the cholangioid luminal area ( Figure 5) showing that NHCderived cholangioids are responsive to secretin and are functionally active.
Pathophysiology
Our previous studies indicated that cholangiocyte senescence is an important cellular phenotype in PSC and that cholangiocytes in liver biopsies from PSC patients express increased levels of the SASP pro-inflammatory factors IL-6, IL-8, CCL2, and PAI-1. 2 We also reported that cholangiocytes isolated from PSC patients show characteristics of cellular senescence, ie, SA-β-gal expression as well as markers of SASP, such as, IL-6, IL-8, and CCL2 expression. 18 Furthermore, previously we were able to induce senescence of NHCs on cholangiocyte monolayers using hydrogen peroxide (H 2 O 2 ) 2 and we were able to reproduce that outcome here in cholangioids ( Figure 6 ). In addition, we were also able to recapitulate the senescence phenotype in our 3D model by using a cholangiocyte cell line from a patient with PSC that was previously isolated and characterized by our group. 18 We confirmed senescence using a qualitative SA-β-gal assay as shown on Figure 6a . A quantitative SA-β-gal technique demonstrated 1.62 ± 0.02-and 2.64 ± 0.09-fold increase senescence over control for the NHC-sen and PSC cholangioids, respectively (Po0.02) (Figure 6b ). Western blotting analysis depicted an increase in the senescence marker p-16 with the H 2 O 2 treatment and in PSC cholangioids (Figure 6c) , consistent with the previous reports from our group. We also detected the expression of the senescent marker γH2A.x and (Figure 6d ) and found that the mean fluorescence intensity of the NHCsen cholangioids was upregulated 8.8 ± 1.4-and 12.7 ± 3.4fold for γH2A.x and IL-6, respectively, over the control cholangioids (Po0.01) ( Figure 6e ). Interestingly, we observed that 41 ± 16% of the NHC-sen cholangioids and virtually all of the PSC cholangioids failed to form lumens; in contrast all the NHC cholangioids formed lumens. Quantitative phase contrast imaging showed that NHC-sen cholangioids displayed a smaller diameter and a slower rate of growth as they progressed from day 5 to day 20 (Figure 7a) . A similar size reduction was observed in PSC cholangioids as well (Figure 7b ). Unlike the NHC cholangioids, the PSC cholangioids did not exhibit polarized distribution of GM130, and the SR and secretin stimulation did not result in an increase in PSC cholangioid size (data not shown). Our lab has previously reported that senescent cholangiocytes become highly secretory including the release of extracellular vesicles (EVs) or exosomes. Here we show that the senescent cholangioids also become highly secretory. Based on Q-PCR studies, the senescent cholangioids upregulate typical markers of senescence such as P21, βGal, and p16 and generate increased levels of pro-inflammatory cytokines such as CCL2 and IL-8 (Figure 8a) . Consistent with this secretory phenotype, senescent cholangioids also release an increased number of EVs (Figure 8b) . These EVs, when characterized by immunoblotting, are positive for exosomal markers such as FN, Alix, TfR, and Cd81 (Figure 8c ). Nanotracking analysis (NTA) also shows the size of these EVs to be around 106 nm, consistent with the size of exosomes (Figure 8d ). Due to the limited availability of PSC cells, we were not able to generate PSC cholangioids to isolate exosomes. Next, to test whether we could recapitulate the macrophage accumulation phenotype of PSC 3 in our model, we cocultured normal and PSC cholangioids with a commonly used human macrophage cell line, THP-1. 25, 26 After 24 h in culture, the co-cultures were fixed and stained for CK7 and CD11B, the former a marker for cholangiocytes and the latter a marker of macrophage activation (Figure 9a ). The number of THP-1 cells associated with PSC cholangioids was 7.6 ± 1.6 (Po0.03) compared to 1.3 ± 0.6 for the control cholangioids (Figure 9b ). Furthermore, conditioned media experiments revealed that cell-free media derived from NHC-sen cholangioids resulted in a two-fold increase in the migration of THP-1 cells, compared to media derived from NHC-Ctrl cholangioids (Figure 9c ).
DISCUSSION
In this study, we describe the establishment and characterization of cholangioids, a novel, 3D model of cultured cholangiocytes to study the pathogenesis of PSC. Beginning with cholangiocyte cell lines, we generated 3D spheroids that resemble bile ducts, describing them morphologically and biochemically, and demonstrating that these cholangioids have functional features of both normal and senescent cholangiocytes. The data support the utility of this in vitro model to study the pathogenesis of PSC and perhaps other cholangiopathies. Also, to our knowledge, this is the first report describing isolation of exosomes from normal and senescent human cholangiocytes in 3D culture. The SASP is a characteristic feature of senescent cells and is increasingly thought to play a pathophysiologic role in biliary disease. 2 Given that cellular senescence is a prominent feature of the cholangiocytes from patients with PSC, generating a 3D culture model that maintains the functional features of senescence and the SASP represents an important advance. The method we describe in this manuscript was a modified version of the protocol described by Debnath et al. 21 The advantages of using this method were that (i) we could monitor the growth of the cholangioids via bright-field microscopy very easily; (ii) the growth of the cholangioids was consistent across different experiments; (iii) live images of the cholangioids interacting with macrophages using confocal microscopy could be performed and these same samples could then be fixed for immunofluorescence analysis; and (iv) the immunofluorescence technique in this protocol is very simple. As we cultured our cholangioids for 20 days, our protocol required the use of undiluted Matrigel, as diluting it compromises the formation of the 3D structure. The ability of cholangioids to form lumens allows manipulation of lumen size, as we did with secretin, an assay that cannot be performed on cells cultured on plastic. Furthermore, interactions between cells and their extracellular microenvironment and changes in the stiffness of the extracellular microenvironment are better visualized in a 3D compared to a 2D model. Thus, our 3D in vitro model has several advantages compared to cells cultured on plastic.
Several groups have shown that cholangiocytes form spheroids with a lumen in 3D culture, 10, [27] [28] [29] [30] however this is the first report showing that senescent cholangioids, both experimentally induced or derived from PSC cholangiocytes, lack a lumen. The failure to form lumens could be a hallmark of PSC disease, as half of our NHC-sen and all of our PSC cholangioids did not form lumens. The reasons for this consistent observation remain unclear at this time. However, Tanimizu et al 28 showed that organoids that failed to form a luminal space were weakly positive for CK19 and had high expression of albumin. Another group also showed that Normal and senescent cholangioids L Loarca et al albumin − /CK19+ cells form more and larger organoids when compared to albumin+/CK19 − organoids. 31 Overall, this suggests that lumens are better-formed in organoids that highly or exclusively express cholangiocyte markers with a relative lack of hepatocyte markers. Western blot analysis of NHC-control and NHC-sen cholangioids showed similar levels of CK7 and CK19 expression ( Figure 6c ), and both cholangioids lack expression of albumin (data not shown). We have, at this point, no mechanistic explanation for why NHC-sen and PSC cells lack a central lumen, but we speculate that the percentage of cells in each of these cholangioid subtypes that were senescent may contribute to the differences. Although senescence is defined as terminal growth arrest, it is notable that the senescent and PSC cholangioids were still able to form cholangioids. We believe that the explanation for this is that the cells in this system are not uniformly senescent. The ability to expand and form cholangioids likely depends primarily on the non-senescent components of this model. Consistent with this, senescent and PSC cholangioids are smaller and have a slower growth rate than the corresponding controls, as would be expected if a proportion of the cells are senescent.
Macrophages are important cells of the immune system that are mobilized in response to an infection or accumulating damaged cells. The immunopathogenesis of PSC appears to involve the activation and recruiting of the innate immune system. 3 Here we showed that our NHC-sen cholangioids retain the expression of profibroinflammatory SASP components. 2, 18 Co-culture of macrophages with cholangioids demonstrated that macrophages associate with and appear to be intercalated within the PSC cholangioid walls. The mechanisms of this phenomenon and the consequences of this cell-cell interaction remain to be determined, and our model provides an ideal system to interrogate this observation further.
In conclusion, studies on the pathogenesis of PSC have been hindered by the lack of a reliable 3D in vitro model of this disease. The model presented in this work recapitulates the senescence and SASP as well as the macrophage recruitment observed in PSC. The mechanisms by which macrophages are recruited to PSC can be studied with this model, and the broader question of how activated cholangiocytes interact with cells in the peribiliary extracellular matrix can be explored. 
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